leisure time -WSS

leisure time

author：fashion 2025-09-27 09:46:01 - browse：32228

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Change Healthcare can notify patients about the breach, HHS says

focus

WSS

CRISPR pioneers react to Casgevy, first gene

Weight loss drug costs may need more research, senator suggests

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Wegovy, Zepbound and weight loss drugs that preserve muscle

Cord blood banking comes at a high cost to babies

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

explore

leisure time

hotspot

How to save PrEP access — and even expand it

Woman returns to dialysis after doctors remove transplanted pig kidney

Medical leaders decry Supreme Court decision on affirmative action

Woman returns to dialysis after doctors remove transplanted pig kidney

In age of alternative facts, a scholarly course on calling out crap

Congress must reauthorize a committee to support older Americans

Medicare proposal to cover medical devices draws a mixed reaction

NYU radiologists take on the challenge of expensive MRI machines

Cancer drug shortages should be causing more outrage

Gain of function research would be limited under House proposal

leisure time

With trial win, GSK could get blood cancer drug back on market

See how much Covid

Weight loss drug costs may need more research, senator suggests

Childhood cancer progress stalls for Black, Hispanic kids: Report

Poor hospice wound care hurts patients and families

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

focus

focus

focus

hotspot